BATIRAXCEPT

UNII:	B6840JH4EB
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	BATIRAXCEPT
GSRS Full Record:	B6840JH4EB i

2268717-61-7
8-202-TYROSINE-PROTEIN KINASE RECEPTOR UFO (14-SERINE,54-VALINE,69-GLYCINE,74-ALANINE,109-ARGININE) (HUMAN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C REGION C-TERMINAL FRAGMENT), DIMER
ARAVIVE-S6
AVB-500
AVB-S6-500
AVBS6500
AXL FC FUSION PROTEIN AVB-S6-500
BATIRAXCEPT [USAN]
Batiraxcept [WHO-DD]
HUMAN TYROSINE-PROTEIN KINASE RECEPTOR UFO (AXL ONCOGENE, EC=2.7.10.1) (8-202) MODIFIED FRAGMENT (G14>S(7), A54>V(47), D69>G(62), V74>A(67), G109>R(102)) (1-195) FUSION PROTEIN WITH TETRAGLYCYLSERYL LINKER (196-200) FUSION PROTEIN WITH IGHG1*03 FC MODIFIED FRAGMENT ((HINGE DEL-(1-5)>(201-210)), CH3(K107>DEL(427))) (201-426),DIMER (206-206':209-209')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA
RUGA-S6
S6-500C
batiraxcept [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BATIRAXCEPT

Synonyms and Mappings

Resources